News Archives for August 2019

Recent News

ASGCT Submits Comments to WHO Advisory Committee
August 22, 2019
Advocacy Policy Updates

ASGCT submitted comments on August 16 to the World Health Organization’s (WHO) Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing regarding guidance to governments, institutions, and researchers on scientific, ethical, social, and legal challenges related to both germline and somatic cell human genome editing.

ASGCT, NORD Partner for Free Educational Gene Therapy Webinars
August 19, 2019
Advocacy Education

Have you heard about gene therapy? Do you want to learn about the history of gene therapy, which gene therapies are currently available and what the future may hold? ASGCT and NORD partner to host the first of five educational gene therapy webinars, "Gene Therapy: Yesterday, Today and Tomorrow," on August 29 at noon EST.

CAR T-Cell Therapy Covered by Medicare, but Still Inadequately Reimbursed

An announcement that the Centers for Medicare & Medicaid Services will cover CAR T-cell therapy is welcome news, but ASGCT remains concerned about reimbursement levels for CAR T-cell therapies for Medicare beneficiaries provided in the inpatient setting.

What's It Like to Attend the ASGCT Annual Meeting?
August 01, 2019

Ever wondered what it's like to attend the ASGCT Annual Meeting? Join four of our gene and cell therapy pros, all of whom hold very different roles in ASGCT, as they attend the premier event in the booming field of gene and cell therapy.

ASGCT Policy Summit
November 4 – 6 | Washington D.C.